TORONTO, Sept. 18 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, announced that Stephen P. DeFalco, President and CEO, will present at the UBS Global Life Sciences Conference in New York City on Tuesday, September 26th, at 4:30pm (EST). Interested parties may access the webcast starting at 7:30pm on September 26th by visiting the "Latest News" section of the MDS home page at http://www.mdsinc.com/. An audio archive of the presentation will also be available under "Webcasts & Presentations" in our "For Investors" section until October 28, 2006. MDS Inc. is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radio therapeutics, and analytical instruments. MDS has more than 8,800 highly skilled people in 28 countries. Find out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Vice-President, Investor Relations and External Communications, (416) 675-6777 ext. 4721,

Copyright